Graduated in Chemistry from UNESP (1993), master's degree in Chemistry/Physical Chemistry from UNESP (1996) and PhD in Chemistry/Physical Chemistry from UNESP (2001) and PhD in Materials Science from LURE-Université Paris-Sud (2001 ). Currently Adjunct Professor at the Faculty of Pharmaceutical Sciences-UNESP-Araraquara. Experience in the area of Chemistry and Materials, with an emphasis on Physical Chemistry and nanomaterials, working mainly on the following topics: colloids, nanomaterials, controlled drug release, SAXS, sol-gel and organic-inorganic hybrid materials. CNPq Productivity Scholarship 2. Master's and doctoral advisor. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The specific release of active molecules presents a major challenge for the treatment of several diseases, in particular cancer. The active molecules must be able to overcome barriers separating them from the site of administration or the desired site of action. For this, carrier and controlled drug delivery systems have been used. In addition to the vectorization of active molecules to s…
The specific release of active agents represents a major challenge for the treatment of various diseases, particularly cancer. The active molecules must be able to overcome barriers that separate them from the site of administration or site of action desired. The design of nanosystems capable of delivering the active ingredient, to improve their distribution and limit side effects, repres…
(Only some records are available in English at this moment)
Nanostructured inorganic materials have some advantages such as chemical stability, high electrical and thermal conductivity, catalytic activity, relatively low production cost, and, in some cases, potent antimicrobial action against bacteria, viruses, fungi, and protozoa. In this context, nanoparticles based on zinc oxide are highlighted by their physical, optical, and biological propert…
Controlled drug release systems are part of a promising pharmaceutical segment, capable of providing greater stability for the drug and greater therapeutic efficacy, that can reduce adverse effects for treatments of various diseases such as cancer. However, most materials still present as main limitation the low capacity of large drug mass. To overcome this limitation, metal-organic frame…
Metal-organic frameworks are coordination polymers that have a structure with high crystallinity and great porosity. This new class of materials has been studied as a controlled drug delivery system. There is also the possibility of developing these materials using biocompatible organic linkers and with biological activity, giving rise to BioMOFs (from English: Biocompatible Metal-Organic…
(Only some records are available in English at this moment)
This project is associated with FAPESP doctorate fellowship process number 2017/16074-4. In recent years, innovation in pharmaceutical research focuses on the development of theranostic systems, which combine two functions: one diagnostic and other therapeutic, thanks to the simultaneous incorporation into nanosystems of therapeutic and image agents. The aim of this project is, during the…
This Project is associated to FAPESP doctorate fellowship process number 2016/11563-4, entitled "Supramolecular capsules derived from metal-organic framework for drug delivery". The research will be realized under supervisor of the Dr. Christian Serre (Institut des Matériaux Poreux de Paris, FRE 2000 CNRS, Ecole Supérieure de Physique et de Chimie Industrielles de Paris (ESPCI) and Ecole …
The specific release of active ingredients is a major challenge for the treatment of various diseases, especially cancer. The active molecules must be able to overcome the barriers that separate the administration site or desired site of action. The design of nanosystems capable of carrying the active ingredient, to improve its distribution and to limit the side effects, is an important a…
(Only some records are available in English at this moment)
| 7 / 5 | Completed research grants |
| 16 / 13 | Completed scholarships in Brazil |
| 5 / 5 | Completed scholarships abroad |
| 28 / 23 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID